#17Metabolic & Frontier
SLU-PP-332
estrogen-related-receptor pan-agonist research small molecule
Evidence: animalReviewed 2026-07-25
Investigated uses
- No adequately documented human investigated use for the exact catalog identity/formulation was identified; any vendor-promoted goals were excluded from evidence grading.
Mechanism and hypotheses
- SLU-PP-332 is a synthetic pan-agonist of estrogen-related receptors studied in mice.
- Hypothesized: “Exercise mimetic,” metabolic and endurance effects have not been established in humans.
Human evidence
- Exercise-endurance and metabolic effects were reported in mice. Limitations: No established human exposure or safety data.
Safety highlights
- Unknown or insufficiently characterized for the exact catalog product.
- Identity, purity, sterility, endotoxin, aggregation, immunogenicity, concentration and route-specific risks are not adequately characterized.
Regulatory context
No FDA-approved product matching the exact catalog presentation was identified in this review.
Sources used for this entry
- Synthetic ERR agonist SLU-PP-332 increases exercise endurance in mice — ACS Chemical Biology / PubMed
- PubMed search: SLU-PP-332 — PubMed
- Drugs@FDA database — U.S. Food and Drug Administration
- EMA medicines search — European Medicines Agency